NOVONIX LTD-ADR
NVXNASDAQUS Equity
$693.73▼ $19.08 (−2.75%)
Simulated price1h—
24h▼ 2.8%
7d▲ 173116.0%
14d▲ 185339.7%
30d▲ 150743.7%
1y▲ 50909.6%
🏦Market Cap
$187.76B
Mid Cap
📈Revenue Growth (YoY)
-17.2%
Declining
📊Gross Margin
-372.3%
Thin
💵FCF Margin
—
⚖️P/S Ratio
18.2x
Expensive
Otter Score
49
Weak
Trading Snapshot
- Day Range
- $689.62 – $697.64
- 52-Week Range
- $0.14 – $1.02
- Volume
- $2.25B
- Avg Volume
- $2.74B
- Shares Outstanding
- 997.6M
- Next Earnings
- Sep 12, 2026
Fundamentals Snapshot
- Annual Revenue
- $19.56B
- Last Q Revenue
- $5.03B
- P/E Ratio
- —
- P/S Ratio
- 18.2x
- EPS (TTM)
- $-0.13
- Dividend Yield
- —
Why Investors Own NVX
- ✓High-growth profile — revenue up +38.5% YoY with expanding US Equity exposure.
- ✓Healthy economics — 31% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$19.56B▲ +37.1% YoY
Gross Margin (TTM)
31.4%▲ +0.0% YoY
Operating Income (TTM)
$5.09B▲ +37.1% YoY
Free Cash Flow (TTM)
$2.35B▲ +37.1% YoY
About NOVONIX LTD-ADR
A company profile for NOVONIX LTD-ADR isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
49/100
Analyst Price Target
ⓘAverage Target
$707.08
▲ +1.9% Upside
High Target$875.93
Low Target$651.13
Based on 27 analysts
Latest News & Updates
🚀
CNBC·2h ago
NOVONIX LTD-ADR tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Reuters·5h ago
Analysts lift NVX price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
NOVONIX LTD-ADR announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.